BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 35069805)

  • 1. Clinical characteristics, long-term functional outcomes and relapse of anti-LGI1/Caspr2 encephalitis: a prospective cohort study in Western China.
    Guo K; Liu X; Lin J; Gong X; Li A; Liu Y; Zhou D; Hong Z
    Ther Adv Neurol Disord; 2022; 15():17562864211073203. PubMed ID: 35069805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features of 28 cases of anti
    Feng J; Li J; Xie Y; Lü Y; Bi F; Zhou J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 48(3):386-396. PubMed ID: 37164922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features and outcomes of leucine-rich glioma-inactivated protein 1 and contactin protein-like 2 antibody-associated autoimmune encephalitis in a Chinese cohort.
    Li HY; Qiao S; Cui CS; Feng F; Liu XW; Yang XD
    J Clin Neurosci; 2022 Jul; 101():137-143. PubMed ID: 35597061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic Spectrum of CASPR2 and LGI1 Antibodies Associated Neurological Disorders in Children.
    Jiang Y; Tan C; Li T; Song X; Ma J; Yao Z; Hong S; Li X; Jiang L; Luo Y
    Front Pediatr; 2022; 10():815976. PubMed ID: 35463890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-LGI1, anti-GABABR, and Anti-CASPR2 encephalitides in Asia: A systematic review.
    Ghimire P; Khanal UP; Gajurel BP; Karn R; Rajbhandari R; Paudel S; Gautam N; Ojha R
    Brain Behav; 2020 Oct; 10(10):e01793. PubMed ID: 32783406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune encephalitis with anti-leucine-rich glioma-inactivated 1 or anti-contactin-associated protein-like 2 antibodies (formerly called voltage-gated potassium channel-complex antibodies).
    Bastiaansen AEM; van Sonderen A; Titulaer MJ
    Curr Opin Neurol; 2017 Jun; 30(3):302-309. PubMed ID: 28248701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seizure underreporting in LGI1 and CASPR2 antibody encephalitis.
    Baumgartner T; Pitsch J; Olaciregui-Dague K; Hoppe C; Racz A; Rüber T; Becker A; von Wrede R; Surges R
    Epilepsia; 2022 Sep; 63(9):e100-e105. PubMed ID: 35735209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rituximab Treatment and Long-term Outcome of Patients With Autoimmune Encephalitis: Real-world Evidence From the GENERATE Registry.
    Thaler FS; Zimmermann L; Kammermeier S; Strippel C; Ringelstein M; Kraft A; Sühs KW; Wickel J; Geis C; Markewitz R; Urbanek C; Sommer C; Doppler K; Penner L; Lewerenz J; Rößling R; Finke C; Prüss H; Melzer N; Wandinger KP; Leypoldt F; Kümpfel T;
    Neurol Neuroimmunol Neuroinflamm; 2021 Nov; 8(6):. PubMed ID: 34599001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinction between anti-VGKC-complex seropositive patients with and without anti-LGI1/CASPR2 antibodies.
    Yeo T; Chen Z; Yong KP; Wong PYW; Chai JYH; Tan K
    J Neurol Sci; 2018 Aug; 391():64-71. PubMed ID: 30103974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum and CSF cytokine levels mirror different neuroimmunological mechanisms in patients with LGI1 and Caspr2 encephalitis.
    Körtvelyessy P; Goihl A; Guttek K; Schraven B; Prüss H; Reinhold D
    Cytokine; 2020 Nov; 135():155226. PubMed ID: 32799011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term seizure outcomes in patients with autoimmune encephalitis: A prospective observational registry study update.
    Liu X; Guo K; Lin J; Gong X; Li A; Zhou D; Hong Z
    Epilepsia; 2022 Jul; 63(7):1812-1821. PubMed ID: 35357695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contemporary advances in antibody-mediated encephalitis: anti-LGI1 and anti-Caspr2 antibody (Ab)-mediated encephalitides.
    Seery N; Butzkueven H; O'Brien TJ; Monif M
    Autoimmun Rev; 2022 May; 21(5):103074. PubMed ID: 35247644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic Resonance Imaging Characteristics of LGI1-Antibody and CASPR2-Antibody Encephalitis.
    Kelly MJ; Grant E; Murchison AG; Binks S; Ramanathan S; Michael S; Handel AE; Handunnetthi L; Uy CE; Soltys JN; Dubey D; Day GS; Lopez-Chiriboga AS; Flanagan EP; Sheerin F; Irani SR
    JAMA Neurol; 2024 May; 81(5):525-533. PubMed ID: 38497971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Leucine-Rich Glioma Inactivated Protein 1, Contactin-Associated Protein 2, and Contactin 2 Antibodies With Clinical Features and Patient-Reported Pain in Acquired Neuromyotonia.
    Vincent A; Pettingill P; Pettingill R; Lang B; Birch R; Waters P; Irani SR; Buckley C; Watanabe O; Arimura K; Kiernan MC
    JAMA Neurol; 2018 Dec; 75(12):1519-1527. PubMed ID: 30242309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycophenolate mofetil reduces the risk of relapse in anti-leucine-rich glioma-inactivated protein 1 encephalitis: a prospective observational cohort study.
    Liu M; Xu X; Fan S; Ren H; Zhao Y; Guan H
    Neurol Sci; 2024 Jan; 45(1):253-260. PubMed ID: 37580515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sleep Disorders in Leucine-Rich Glioma-Inactivated Protein 1 and Contactin Protein-Like 2 Antibody-Associated Diseases.
    Lin N; Hao H; Guan H; Sun H; Liu Q; Lu Q; Jin L; Ren H; Huang Y
    Front Neurol; 2020; 11():696. PubMed ID: 32849186
    [No Abstract]   [Full Text] [Related]  

  • 17. Leucine-rich Glioma-inactivated 1 Encephalitis Followed by Isaacs Syndrome: Alternating Presence of Pathogenic Autoantibodies to Leucine-rich Glioma-inactivated 1 and Contactin-associated Protein-like 2.
    Murayama A; Sugaya K; Hara M; Kawazoe T; Tobisawa S; Nakajima H; Takahashi K
    Intern Med; 2023 Jun; 62(11):1659-1663. PubMed ID: 36223927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct movement disorders in contactin-associated-protein-like-2 antibody-associated autoimmune encephalitis.
    Gövert F; Abrante L; Becktepe J; Balint B; Ganos C; Hofstadt-van Oy U; Krogias C; Varley J; Irani SR; Paneva S; Titulaer MJ; de Vries JM; Boon AJW; Schreurs MWJ; Joubert B; Honnorat J; Vogrig A; Ariño H; Sabater L; Dalmau J; Scotton S; Jacob S; Melzer N; Bien CG; Geis C; Lewerenz J; Prüss H; Wandinger KP; Deuschl G; Leypoldt F
    Brain; 2023 Feb; 146(2):657-667. PubMed ID: 35875984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Chinese female Morvan patient with LGI1 and CASPR2 antibodies: a case report.
    Zhang L; Lu Q; Guan HZ; Mei JH; Ren HT; Liu MS; Peng B; Cui LY
    BMC Neurol; 2016 Mar; 16():37. PubMed ID: 26983964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Features and Long-Term Outcomes of Anti-Leucine-Rich Glioma-Inactivated 1 Encephalitis: A Multi-Center Study.
    Qiao S; Wu HK; Liu LL; Wang ML; Zhang RR; Han T; Liu XW
    Neuropsychiatr Dis Treat; 2021; 17():203-212. PubMed ID: 33531809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.